Trial Profile
Phase Ib/IIa study of bevacizumab alone and in combination with ALG 1001 in patients with diabetic macular oedema
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 09 May 2013
Price :
$35
*
At a glance
- Drugs Risuteganib (Primary) ; Bevacizumab
- Indications Diabetic macular oedema
- Focus Adverse reactions; Therapeutic Use
- 09 May 2013 New trial record